AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
ANTI-PROTHROMBIN ANTIBODIES AND THEIR RELATION WITH THROMBOSIS AND LUPUS ANTICOAGULANT
Authors: DEGROOT PG HORBACH DA SIMMELINK MJA VANOORT E DERKSEN RHWM
Citation: Pg. Degroot et al., ANTI-PROTHROMBIN ANTIBODIES AND THEIR RELATION WITH THROMBOSIS AND LUPUS ANTICOAGULANT, Lupus, 7, 1998, pp. 32-36
THE PREVALENCE OF A NON-PHOSPHOLIPID-BINDING FORM OF BETA(2)-GLYCOPROTEIN-I IN HUMAN PLASMA
Authors: HORBACH DA VANOORT E TEMPELMAN MJ DERKSEN RHWM DEGROOT PG
Citation: Da. Horbach et al., THE PREVALENCE OF A NON-PHOSPHOLIPID-BINDING FORM OF BETA(2)-GLYCOPROTEIN-I IN HUMAN PLASMA, Thrombosis and haemostasis, 80(5), 1998, pp. 791-797
THE CONTRIBUTION OF ANTI-PROTHROMBIN-ANTIBODIES TO LUPUS ANTICOAGULANT ACTIVITY - DISCRIMINATION BETWEEN FUNCTIONAL AND NONFUNCTIONAL ANTI-PROTHROMBIN-ANTIBODIES
Authors: HORBACH DA VANOORT E DERKSEN RHWM DEGROOT PG
Citation: Da. Horbach et al., THE CONTRIBUTION OF ANTI-PROTHROMBIN-ANTIBODIES TO LUPUS ANTICOAGULANT ACTIVITY - DISCRIMINATION BETWEEN FUNCTIONAL AND NONFUNCTIONAL ANTI-PROTHROMBIN-ANTIBODIES, Thrombosis and haemostasis, 79(4), 1998, pp. 790-795
HOMOCYSTEINE, METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOEMBOLIC EVENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE COHORT STUDY
Authors: FIJNHEER R ROEST M HAAS FJLM DEGROOT PG DERKSEN RHWM
Citation: R. Fijnheer et al., HOMOCYSTEINE, METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOEMBOLIC EVENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A RETROSPECTIVE COHORT STUDY, Journal of rheumatology, 25(9), 1998, pp. 1737-1742
DEHYDROEPIANDROSTERONE (DHEA) AND SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DERKSEN RHWM
Citation: Rhwm. Derksen, DEHYDROEPIANDROSTERONE (DHEA) AND SYSTEMIC LUPUS-ERYTHEMATOSUS, Seminars in arthritis and rheumatism, 27(6), 1998, pp. 335-347
TRANSIENT MONOCULAR BLINDNESS AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DONDERS RCJM KAPPELLE LJ DERKSEN RHWM ALGRA A HORBACH DA DEGROOT PG VANGIJN J
Citation: Rcjm. Donders et al., TRANSIENT MONOCULAR BLINDNESS AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Neurology, 51(2), 1998, pp. 535-540
DEFORMING ARTHROPATHY OR LUPUS AND RHUPUS HANDS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: VANVUGT RM DERKSEN RHWM KATER L BIJLSMA JWJ
Citation: Rm. Vanvugt et al., DEFORMING ARTHROPATHY OR LUPUS AND RHUPUS HANDS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Annals of the Rheumatic Diseases, 57(9), 1998, pp. 540-544
VASOOCCLUSIVE RETINOPATHY - IS IT A CLASSICAL CLINICAL MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME - REPLY
Authors: DERKSEN RHWM
Citation: Rhwm. Derksen, VASOOCCLUSIVE RETINOPATHY - IS IT A CLASSICAL CLINICAL MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME - REPLY, Lupus, 6(7), 1997, pp. 618-618
ANTIPROTHROMBIN ANTIBODIES DO NOT NECESSARILY CAUSE LUPUS ANTICOAGULANT ACTIVITY
Authors: HORBACH DA VANOORT E DERKSEN RHWM DEGROOT PG
Citation: Da. Horbach et al., ANTIPROTHROMBIN ANTIBODIES DO NOT NECESSARILY CAUSE LUPUS ANTICOAGULANT ACTIVITY, Thrombosis and haemostasis, 1997, pp. 2198-2198
USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/
Authors: BOOTSMA H DERKSEN RHWM JAEGERS SMHJ SPRONK PE BIJL M KATER L KALLENBERG CGM
Citation: H. Bootsma et al., USEFULNESS OF THE SLICC ACR DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS/, Arthritis and rheumatism, 40(9), 1997, pp. 775-775
LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT
Authors: KALLENBERG CGM BOOTSMA H SPRONK PE TERBORG EJ DERKSEN RHWM KATER L
Citation: Cgm. Kallenberg et al., LABORATORY TESTS AS PREDICTORS OF FLARES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - COMMENT, Arthritis and rheumatism, 40(2), 1997, pp. 393-393
PROTEIN-C AND OTHER COFACTORS INVOLVED IN THE BINDING OF ANTIPHOSPHOLIPID ANTIBODIES - RELATION TO THE PATHOGENESIS OF THROMBOSIS
Authors: DEGROOT PG HORBACH DA DERKSEN RHWM
Citation: Pg. Degroot et al., PROTEIN-C AND OTHER COFACTORS INVOLVED IN THE BINDING OF ANTIPHOSPHOLIPID ANTIBODIES - RELATION TO THE PATHOGENESIS OF THROMBOSIS, Lupus, 5(5), 1996, pp. 488-493
CLINICAL MANIFESTATIONS AND MANAGEMENT OF THE ANTIPHOSPHOLIPID SYNDROME
Authors: DERKSEN RHWM
Citation: Rhwm. Derksen, CLINICAL MANIFESTATIONS AND MANAGEMENT OF THE ANTIPHOSPHOLIPID SYNDROME, Lupus, 5(2), 1996, pp. 167-169
PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: DERKSEN RHWM GMELIGMEIJLING FHJ DEGROOT PG
Citation: Rhwm. Derksen et al., PRIMARY ANTIPHOSPHOLIPID SYNDROME EVOLVING INTO SYSTEMIC LUPUS-ERYTHEMATOSUS, Lupus, 5(1), 1996, pp. 77-80
LUPUS ANTICOAGULANT IS THE STRONGEST RISK FACTOR FOR BOTH VENOUS AND ARTERIAL THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON BETWEEN DIFFERENT ASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES
Authors: HORBACH DA VANOORT E DONDERS RCJM DERKSEN RHWM DEGROOT PG
Citation: Da. Horbach et al., LUPUS ANTICOAGULANT IS THE STRONGEST RISK FACTOR FOR BOTH VENOUS AND ARTERIAL THROMBOSIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - COMPARISON BETWEEN DIFFERENT ASSAYS FOR THE DETECTION OF ANTIPHOSPHOLIPID ANTIBODIES, Thrombosis and haemostasis, 76(6), 1996, pp. 916-924
FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: FIJNHEER R HORBACH DA DONDERS RCJM VILE H VONOORT E NIEUWENHUIS HK GMELIGMEIJLING FHJ DEGROOT PG DERKSEN RHWM
Citation: R. Fijnheer et al., FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Thrombosis and haemostasis, 76(4), 1996, pp. 514-517
COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY
Authors: BOOTSMA H SPRONK PE LIMBURG PC MEYLING FHJG KATER L DERKSEN RHWM KALLENBERG CGM
Citation: H. Bootsma et al., COMPARISON OF SENSITIVITY TO CHANGE OF 2 CLINICAL MEASURES OF LUPUS DISEASE-ACTIVITY - A LONGITUDINAL PROSPECTIVE-STUDY, Arthritis and rheumatism, 39(9), 1996, pp. 261-261
FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: HORBACH DA FIJNHEER R VANOORT E DONDERS RCJM DEGROOT PG DERKSEN RHWM
Citation: Da. Horbach et al., FACTOR-V LEIDEN, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 39(9), 1996, pp. 1050-1050
THE PRESENCE OF ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES AND THEIR CORRELATIONS WITH VENOUS AND ARTERIAL THROMBOSIS
Authors: HORBACH DA DERKSEN RHWM DEGROOT PG
Citation: Da. Horbach et al., THE PRESENCE OF ANTI-BETA(2)-GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES AND THEIR CORRELATIONS WITH VENOUS AND ARTERIAL THROMBOSIS, Annales de medecine interne, 147, 1996, pp. 42-43
IMMUNOPATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: KATER L GMELIGMEYLING FHJ DERKSEN RHWM DELAFAILLE HB
Citation: L. Kater et al., IMMUNOPATHOGENESIS AND THERAPY OF SYSTEMIC LUPUS-ERYTHEMATOSUS, CLINICAL IMMUNOTHERAPEUTICS, 4(6), 1995, pp. 471-493
ANNEXIN-V IS HIGHLY ABUNDANT IN CELLS WHICH POSSESS A BARRIER FUNCTION BETWEEN BLOOD AND TISSUE AND CIRCULATES IN PLASMAS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
Authors: VANHEERDE WL DEGROOT PG DERKSEN RHWM FREYSSINET JM VROOM TM REUTELINGSPERGER CPM
Citation: Wl. Vanheerde et al., ANNEXIN-V IS HIGHLY ABUNDANT IN CELLS WHICH POSSESS A BARRIER FUNCTION BETWEEN BLOOD AND TISSUE AND CIRCULATES IN PLASMAS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Thrombosis and haemostasis, 73(6), 1995, pp. 1265-1265
ELEVATED ANNEXIN-V LEVELS IN PLASMAS OF PATIENTS WITH AUTOIMMUNE-DISEASES
Authors: VANHEERDE WL DEGROOT PG DERKSEN RHWM FREYSSINET JM REUTELINGSPERGER CPM
Citation: Wl. Vanheerde et al., ELEVATED ANNEXIN-V LEVELS IN PLASMAS OF PATIENTS WITH AUTOIMMUNE-DISEASES, Blood, 86(10), 1995, pp. 3549-3549
SKEWED DISTRIBUTION OF IGG FC RECEPTOR IIA (CD32) POLYMORPHISM IS ASSOCIATED WITH RENAL-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
Authors: DUITS AJ BOOTSMA H DERKSEN RHWM SPRONK PE KATER L KALLENBERG CGM CAPEL PJA WESTERDAAL NAC SPIERENBURG GT GMELIGMEYLING FHJ VANDEWINKEL JGJ
Citation: Aj. Duits et al., SKEWED DISTRIBUTION OF IGG FC RECEPTOR IIA (CD32) POLYMORPHISM IS ASSOCIATED WITH RENAL-DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS, Arthritis and rheumatism, 38(12), 1995, pp. 1832-1836
PROTEIN-C PATHWAY, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS
Authors: DEGROOT PG DERKSEN RHWM
Citation: Pg. Degroot et Rhwm. Derksen, PROTEIN-C PATHWAY, ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS, Lupus, 3(4), 1994, pp. 229-233
PREGNANCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY
Authors: DERKSEN RHWM BRUINSE HW DEGROOT PG KATER L
Citation: Rhwm. Derksen et al., PREGNANCY IN SYSTEMIC LUPUS-ERYTHEMATOSUS - A PROSPECTIVE-STUDY, Lupus, 3(3), 1994, pp. 149-155
Risultati: 1-25 | 26-34